Cargando…
New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019
Autores principales: | Zhang, Chao, Wu, Yi-Long, Zhong, Wen-Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Association for the Study of Lung Cancer. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022460/ https://www.ncbi.nlm.nih.gov/pubmed/35465962 http://dx.doi.org/10.1016/j.jtho.2022.03.001 |
Ejemplares similares
-
Oral probiotics in coronavirus disease 2019: connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials
por: Baindara, P., et al.
Publicado: (2021) -
Enlightenment from clinical trials on Chinese medicine for coronavirus disease 2019 (COVID-19)
por: Pang, Bo, et al.
Publicado: (2020) -
Strategies for the prevention and management of coronavirus disease 2019
por: Guan, Wei-jie, et al.
Publicado: (2020) -
Coronavirus Disease 2019 and Stroke
por: Kim, Jong S.
Publicado: (2020) -
Challenges of coronavirus disease 2019
por: The Lancet Infectious Diseases
Publicado: (2020)